Electrical Geodesics Inc EGI Product Pipeline Analysis, 2017 Update [Report Updated: 28092017] Prices from USD $750

Acquisition
Summary Electrical Geodesics Inc EGI is a medical device company that designs, develops and commercializes noninvasive neurodiagnostic products used to monitor and interpret brain activity. The company's clinical products include geodesic EEG system 400 series, spike detection software, geodesic photogrammetry system, geodesic EEG system 300, geodesic EEG mobile 100 and ETG4000 optical topography system. It provides research products such as geodesic EEG system 400 series, stimulus presentation and experiment control, geodesic photogrammetry system, avatar portable recorder, integrated physiological measurement, PRANA sleep software, nearinfrared spectroscopy system, and others. EGI offers services such as clinical support services, installation services, research education and research support services. The company market its products through its authorized distributors. EGI is headquartered in Eugene, Oregon, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments The report analyzes all pipeline products in development for the company Electrical Geodesics Inc The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date The report provides detailed description of products in development, technical specification and functions The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio To formulate effective Research Development strategies Develop marketentry and market expansion strategies Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio Note: Some sections may be missing if data is unavailable for the company
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.